Bone marrow

System Immune/Lymphatic
SNOMED CT 421320006

Bone marrow

Definition

The soft tissue that fills the cavities of bones.

Also known as medulla ossea, medulla ossium — per UBERON

The Bone marrow is a part of the Immune/Lymphatic.

Also identified as

Associated Diseases

Disease Involvement Source
Acute myeloid leukemia, RUNX1 gene mutation Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, RUNX1 gene mutation Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, t(10;11)(p12;q23) Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, t(10;11)(p12;q23) Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, t(11;15)(p15;q35) Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, t(11;15)(p15;q35) Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, t(15;17)(q24;q21) Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, t(15;17)(q24;q21) Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, t(16;16)(p13.1;q22) Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, t(16;16)(p13.1;q22) Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, t(3;3)(q21.3;q26.2) Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, t(3;3)(q21.3;q26.2) Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, t(3;5)(q25;q34) Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, t(3;5)(q25;q34) Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, t(5;11)(q35;p15) Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, t(5;11)(q35;p15) Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, t(6;11)(q27;q23) Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, t(6;11)(q27;q23) Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, t(6;9)(p23;q34.1) Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, t(6;9)(p23;q34.1) Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, t(7;12)(q36;p13) Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, t(7;12)(q36;p13) Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, Trisomy 8 Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Acute myeloid leukemia, Trisomy 8 Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Acute myelomonocytic leukemia M4 Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Acute myelomonocytic leukemia M4 Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Acute panmyelosis with myelofibrosis Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Acute panmyelosis with myelofibrosis Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Acute promyelocytic leukemia Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Acute promyelocytic leukemia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Acute undifferentiated leukemia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Adult acute lymphoblastic leukemia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Adult acute monocytic leukemia Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Adult acute monocytic leukemia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Aggressive NK-cell leukemia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Aleukemic leukemia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Aleukemic leukemia cutis Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Atypical chronic myeloid leukemia, BCR-ABL1 negative Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Atypical chronic myeloid leukemia, BCR-ABL1 negative Disease Has Primary Anatomic Site NCIT · CC BY 4.0
B acute lymphoblastic leukemia with DUX4 rearrangement Disease Has Primary Anatomic Site NCIT · CC BY 4.0
B acute lymphoblastic leukemia with PAX5 P80R mutation Disease Has Primary Anatomic Site NCIT · CC BY 4.0
B-cell acute lymphoblastic leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) Disease Has Primary Anatomic Site NCIT · CC BY 4.0
B-cell adult acute lymphocytic leukemia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
B-cell childhood acute lymphoblastic leukemia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
B-cell chronic lymphocytic leukemia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
B-cell prolymphocytic leukemia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Bilineal acute myeloid leukemia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Bone marrow cancer Disease Has Associated Anatomic Site NCIT · CC BY 4.0

Showing 51–100 of 226

Drugs Acting Here

Drug Effect Source
Pegaspargase may treat a disease of this organ DERIVED · CC BY 4.0
Peginterferon Alfa-2a may treat a disease of this organ DERIVED · CC BY 4.0
Pentostatin may treat a disease of this organ DERIVED · CC BY 4.0
Ponatinib may treat a disease of this organ DERIVED · CC BY 4.0
Prednisolone may treat a disease of this organ DERIVED · CC BY 4.0
Prednisone may treat a disease of this organ DERIVED · CC BY 4.0
Quizartinib may treat a disease of this organ DERIVED · CC BY 4.0
Revumenib may treat a disease of this organ DERIVED · CC BY 4.0
Rituximab may treat a disease of this organ DERIVED · CC BY 4.0
Ropeginterferon Alfa-2B may treat a disease of this organ DERIVED · CC BY 4.0
Ruxolitinib may treat a disease of this organ DERIVED · CC BY 4.0
Thioguanine may treat a disease of this organ DERIVED · CC BY 4.0
Tretinoin may treat a disease of this organ DERIVED · CC BY 4.0
Venetoclax may treat a disease of this organ DERIVED · CC BY 4.0
Vincristine may treat a disease of this organ DERIVED · CC BY 4.0
Ziftomenib may treat a disease of this organ DERIVED · CC BY 4.0

Showing 51–66 of 66

16 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.